Hinge Health (HNGE) Stock: Buy, Sell, or Hold?
HNGE - Hinge Health, Inc.
$97.94
0.70 (0.72%)
▲
5d:
+6.48%
30d:
+8.8%
90d:
+16.53%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When HNGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HNGE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HNGE shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$148.84
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$92.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HNGE is currently trading at $97.94, which is considered extended relative to its 30-day fair value range of $89.96 to $94.69. The stock's valuation (Forward PE: 32.0) is in line with its historical norms (32.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HNGE is in a strong uptrend. The price is approaching resistance at $98.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $109.31 (+11.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HNGE is in a strong uptrend. The price is approaching resistance at $98.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $109.31 (+11.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$89.96 -
$94.69
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding HNGE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($109.31)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$89.96 -
$94.69
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$89.75
Resistance Level
$98.46
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.03
Wall Street Target
$109.31
(+11.6%)
Revenue Growth (YoY)
53.0%
Earnings Growth (YoY)
-68.4%
Profit Margin
15.2%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
32.0 vs 32.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$97.65
(0%)
2-Year Target
$97.35
(-1%)
3-Year Target
$97.06
(-1%)
3-Yr Target (if PE normalizes)
(PE: 32→32)
$97.86
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.0, Growth: 27.4%)
$202.69
(+107%)
Base:
(SPY PE: 20.4, Growth: 27.4%)
$129.07
(+32%)
Bear:
(PE: 17.3, Growth: 27.4%)
$109.71
(+12%)
📈
Valuation based on Current Earnings
Trailing PE: 11.83 | Current EPS (TTM): $8.22
Bull Case
$53.48
(-45%)
Analyst growth -50.0%, PE expands to 13.0
Base Case
$48.62
(-50%)
Market implied -50.0%, PE stable at 11.8
Bear Case
$66.12
(-33%)
Severe decline -20.0%, PE contracts to 10.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 32.0 to 32.3
Stabilization Target:
$98.75
(+0.8%)
PE Expansion Potential:
+0.8%
Share & Embed Analysis
Last updated: October 02, 2026 6:45 AM ET
Data refreshes hourly during market hours. Next update: 7:45 AM
Data refreshes hourly during market hours. Next update: 7:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HNGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Gabriel M.I. Mecklenburg
SELL
33333 shares
2026-04-21
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 60 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 80 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 41 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 51 HOLD |
Advanced HNGE Option Strategies
Professional options setups generated by AI based on today's HNGE price and gamma walls.